Alyssa Ylescupidez

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Top Venues

Science translational medicine

The Journal of clinical endocrinology and metabolism

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema, Kevan C Herold, Kurt J Griffin, Stephen E Gitelman, Sarah Alice Long, null null, null null
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Science translational medicine 16 (746) (2024)
Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema, Kevan C Herold, Kurt J Griffin, Stephen E Gitelman, Sarah Alice Long, null null, null null
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Science translational medicine 16 (746) (2024)
Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema, Kevan C Herold, Kurt J Griffin, Stephen E Gitelman, Sarah Alice Long, null null, null null
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Science translational medicine 16 (746) (2024)
Alyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, Darrell M Wilson, Andrea K Steck, Jennifer L Sherr, Jason L Gaglia, Christine Bender, Sandra M Lord, Carla J Greenbaum
OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals. The Journal of clinical endocrinology and metabolism (2023)
Alyssa Ylescupidez, Henry T Bahnson, Colin O'Rourke, Sandra Lord, Cate Speake, Carla J Greenbaum
A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes. Nature communications 14 (1) (2023)